Vaxcyte, Inc. Business Finance Contracts & Agreements
16 Contracts & Agreements
- Assignment Agreements (1 contract)
- Investor Rights Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (5)
- Warrant Agreements (4)
- Form of Pre-Funded Warrant (Filed With SEC on January 31, 2024)
- Underwriting Agreement, dated January 30, 2024 (Filed With SEC on January 31, 2024)
- Consent to Assignment and First Amendment by and among ARE-San Francisco No. 63, LLC, Codexis, Inc. and the Registrant, dated September 6, 2023 (Filed With SEC on November 6, 2023)
- Form of Stock Option Grant Notice and Stock Option Agreement (Filed With SEC on August 8, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on April 20, 2023)
- Underwriting Agreement, dated April 18, 2023 (Filed With SEC on April 20, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on October 27, 2022)
- Underwriting Agreement, dated October 25, 2022 (Filed With SEC on October 27, 2022)
- Form of Restricted Stock Unit Grant Notice (Filed With SEC on May 9, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on January 13, 2022)
- Underwriting Agreement, dated January 12, 2022 (Filed With SEC on January 13, 2022)
- Description of Capital Stock (Filed With SEC on March 29, 2021)
- Vaxcyte, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on June 8, 2020)
- Form of common stock certificate of the Registrant (Filed With SEC on June 8, 2020)
- Form of Underwriting Agreement (Filed With SEC on June 8, 2020)
- Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated March 20, 2020 (Filed With SEC on May 22, 2020)
